AlokeVirmaniFinnMD
Cardiology • Baltimore, MDInterventional Cardiology
Medical Director CVPath, Clinical Professor University Of Maryland School of Medicine
Dr. Finn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
University of Maryland Medical Center
Baltimore, MD 21201Phone+1 301-208-2480
Education & Training
Massachusetts General HospitalFellowship, Interventional Cardiology, 2003- Massachusetts General HospitalResidency, Internal Medicine, 2000 - 2002
Vanderbilt University School of MedicineClass of 2000
Certifications & Licensure
MD State Medical License 2015 - 2026
GA State Medical License 2007 - 2017
MA State Medical License 2002 - 2009
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Clinical Trials
- Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI Start of enrollment: 2006 Sep 01
- Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Therapy After Drug Eluting Stent Placement Start of enrollment: 2010 Nov 01
- Optical Frequency Domain Imaging (OFDI) and Vascular Healing After Stent Placement Start of enrollment: 2013 Sep 01
Publications & Presentations
PubMed
- Risk Factors Favoring Plaque Erosion.Tomoyo Hamana, Palak Shah, Alyssa Grogan, Rika Kawakami, Desiree Williams
Current Atherosclerosis Reports. 2024-12-11 - Is the axiom of balloon angioplasty, "the more you gain the more you lose," still true in the era of DCB with paclitaxel?Patrick W Serruys, Akihiro Tobe, Kai Ninomiya, Scot Garg, Aloke V Finn
Cardiovascular Revascularization Medicine. 2024-12-01 - 1 citationsNanoparticle-based itaconate treatment recapitulates low-cholesterol/low-fat diet-induced atherosclerotic plaque resolution.Natalie E Hong, Alice Chaplin, Lin Di, Anastasia Ravodina, Graham H Bevan
Cell Reports. 2024-11-26
Journal Articles
- Long-Term Vasomotion After AbsorbRenu Virmani, Aloke V Finn, ScienceDirect
Lectures
- Fundamentals of Stent Design: The BP-DES Sweet SpotCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- Why SEB Should Be Safer: Insights From Preclinical StudyCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
Authored Content
- Pathological Mechanisms of Left Main Stent FailureMay 2018
- Discontinuity Is It a Major Cause of Scaffold Thrombosis?October 2017
Press Mentions
Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI PatientsMarch 16th, 2022- Unraveling the Mystery of Sudden Cardiac Death with Genetic TestingSeptember 6th, 2021
- Genetics of Unexplained Sudden Cardiac ArrestJune 24th, 2021
- Join now to see all
Grant Support
- Mtor Signaling And Vascular Repair In An Experimental Model Of Diabetes MellitusNational Heart, Lung, And Blood Institute2010–2012
- Defining the Roles of Smooth Muscle Cells and Other Extracellular Matrix Producing Cells in Late Stage Atherosclerotic Plaque PathogenesisLeducq FoundationPresent
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
